Eton Pharmaceuticals (ETON) Operating Income Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) Operating Income Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.12 Bn | 13.10 Mn | 291.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 291.73% |
| Sep 30, 2025 | -367.78% |
| Jun 30, 2025 | 49.74% |
| Mar 31, 2025 | 41.25% |
| Dec 31, 2024 | 131.56% |
| Sep 30, 2024 | 192.88% |
| Jun 30, 2024 | -175.59% |
| Mar 31, 2024 | 68.43% |
| Dec 31, 2023 | -287.66% |
| Sep 30, 2023 | 81.07% |
| Jun 30, 2023 | 389.78% |
| Mar 31, 2023 | 50.19% |
| Dec 31, 2022 | -19.18% |
| Sep 30, 2022 | 50.49% |
| Jun 30, 2022 | 42.37% |
| Mar 31, 2022 | -194.85% |
| Dec 31, 2021 | 117.71% |
| Sep 30, 2021 | 6.78% |
| Jun 30, 2021 | 48.77% |
| Mar 31, 2021 | 160.39% |